Biological Factors: News and Research on Antigens, Differentiation, T-Lymphocyte

MeSH tree: D23.050.301.264.894

Three things to know about teplizumb, the new diabetes drug

The Food and Drug Administration (FDA) recently approved a medication that can delay the onset of type 1 diabetes. This marks the first treatment to change the course of this autoimmune disease since the discovery of insulin ...

Study uncovers possible path for improving T cell therapies

A study led by researchers at the University of Arizona Health Sciences discovered new information about the inner workings of the immune system that could have a profound impact on T cell therapies for cancer and other diseases.

page 2 from 2